【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2012 8
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2012 8
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2012 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2012 11
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2012 12
2.4.1 Abbott Completes Private Placement of Notes for $14.7 Billion 12
2.4.2 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 12
2.4.3 UnitedHealth Group to Acquire 90% Stake in Amil Participacoes for $4.9 Billion 12
2.4.4 HCA Completes Public Offering of Notes for $3.5 Billion 13
2.4.5 HCP Completes Acquisition of Senior Housing Portfolio of Emeritus and Blackstone for $1.7 Billion 13
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2012 14
3.1.1 Top M&A Deals in Q4 2012 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2011 – Q4 2012 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2012 17
3.2.1 Top Initial Public Offerings in Q4 2012 18
3.2.2 Top Secondary Offerings in Q4 2012 18
3.2.3 Top PIPE Deals in Q4 2012 18
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2011–Q4 2012 19
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2011 – Q4 2012 20
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2012 21
3.3.1 Top Venture Financing Deals in Q4 2012 22
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 23
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2012 24
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2011 – Q4 2012 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Last Four Quarters 26
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 27
3.3.7 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2012 28
3.3.8 Top Private Equity Deals in Q4 2012 29
3.3.9 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2011 – Q4 2012 30
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2012 31
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2011 – Q4 2012 33
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 34
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2012 35
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2012 35
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2012 36
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 37
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2011 – Q4 2012 38
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2011 – Q4 2012 39
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 40
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2012 41
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 – Q4 2012 42
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2012 43
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2012 43
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2012 44
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2011 – Q4 2012 45
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 46
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 47
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2011 – Q4 2012 48
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2011 – Q4 2012 49
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 50
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2011 – Q4 2012 50
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2011 – Q4 2012 51
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2011 – Q4 2012 52
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2011 – Q4 2012 53
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2011 – Q4 2012 54
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2011 – Q4 2012 55
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2011 – Q4 2012 56
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 57
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2012 57
7.1.1 Oncology – Deals of the Quarter 58
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2012 59
7.2.1 Central Nervous System – Deals of the Quarter 60
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2012 62
7.3.1 Infectious Disease – Deals of the Quarter 63
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2012 64
7.4.1 Immunology – Deals of the Quarter 65
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2012 66
7.5.1 Metabolic Disorders – Deals of the Quarter 67
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2012 68
7.6.1 Cardiovascular – Deals of the Quarter 69
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2012 70
7.7.1 Gastrointestinal – Deals of the Quarter 71
7.8 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2012 72
7.8.1 Ophthalmology – Deals of the Quarter 73
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2012 74
7.9.1 Respiratory – Deals of the Quarter 75
7.10 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2012 76
7.10.1 Dermatology – Deals of the Quarter 77
8 Deal Summary by Geography 78
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2012 78
8.1.1 North America – Deals of the Quarter 79
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2012 81
8.2.1 Europe – Deals of the Quarter 82
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2012 83
8.3.1 Asia-Pacific – Deals of the Quarter 84
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2012 85
8.4.1 Rest of the World – Deals of the Quarter 86
9 Pharmaceuticals & Healthcare, Global, Top Advisors 87
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Last One Year 87
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Last One Year 88
10 Appendix 89
11 Further Information 93
11.1 Methodology 93
11.2 About GlobalData 93
11.3 Contact Us 94
11.4 Disclosure information 94
11.5 Disclaimer 94
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向（四半期別）：Q4 2012■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2012
■ 発行日：2013年1月31日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160305
■ 調査対象地域：グローバル
- ヒヨコマメの世界市場2018-202297 Pages, November 2018 About this market There is an increase in the consumption of chickpeas due to various factors such as busy lifestyles and the rapidly expanding working population around the globe. These people extensively prefer ready-to-eat light snack food products and convenience foods with high nutrition content such as superfood seed-based products like chickpeas Technavio’s analysts …
- 住宅・商業施設向けセキュリティ製品の世界市場：監視システム、侵入者警報装置、アクセス制御システム、セキュリティソフトウェアAbout Residential and Commercial Security Residential and commercial security is a form of physical security. Because of increasing instances of theft and burglary in residential areas, need for physical security solutions like intruder alarms and electronic locks has increased. Apart from residences, commercial buildings such as retail stores, shopping malls, warehouses, and office buildings also …
- データセンター電源の世界市場予測（～2021）：ソリューション別（配電＆電力計測、電力バックアップ、配線インフラストラクチャ）、サービス別、需要先別、産業別、地域別The global data center power market is estimated to grow from USD 13.54 Billion in 2016 to USD 21.73 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 9.92% during the forecast period. Factors such as growing concern of the data center providers to optimize operational cost of the data center by reducing the cost of data center power is driving the growth of the global data center market …
- Vermilion Energy Inc.：石油・ガスバリューチェーン分析レポート2013Vermilion Energy Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Vermilion Energy Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Vermilion Energy Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- スマート家電の世界市場：洗濯機、乾燥機、エアコン、掃除機、冷蔵庫、食器洗い機、冷凍庫Smart appliances are the next generation of home appliances that have the ability to receive, interpret, and act on a signal received from a user, and then they automatically adjust their operation to save energy. They are equipped with different sensors and designed with connectivity features that can connect to handheld devices such as smartphones and tablets as well as other household appliance …
- 核医学診断装置（PET、SPECT）の世界市場MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts Summary This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has bee …
- 発電機販売の世界市場予測（～2020）The generator sales market is expected to grow at a CAGR of 5.85% from 2015 to 2020. It is projected to reach USD 23.36 Billion by 2020 from an estimated value of USD 17.59 Billion in 2015. The generator sales market is driven by growing demand for uninterrupted and reliable power supply across the globe. Countries are regularly facing blackouts, rolling blackouts, or brownouts, which further affe …
- 世界のポリマー・フォーム市場：ポリウレタン、ポリスチレン、ポリ塩化ビニル、ポリオレフィン、フェノール樹脂、メラミンなどPolymer foam market is dominated by Asia-Pacific region securing more than one third of global market share. China was leading the demand for polymer foam in Asia-Pacific region, growing with the highest CAGR. Europe and North America were following the Asia-Pacific polymer foam market and were home to the largest players of industry such as BASF SE (Germany) and INEOS Styrenics (Switzerland). Bui …
- 糖尿病黄斑浮腫：疫学的予測（～2023）EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023 Summary Macular edema (ME) occurs due to the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. In ME, fluid and protein deposits collect on or under the macula of the eye, due to a breakdown in the blood-retinal barrier. The occurrence of ME is highly frequent …
- センシティブ 歯磨き粉の世界市場2019-2023About this market The increasing demand for natural and organic oral care products will foster the sensitive toothpaste market growth in the forthcoming years. With the rising personal health and dental hygiene, the demand for organic toothpaste for curing tooth sensitivity is quite high. As a result, end-users increasingly prefer oral care products made of organic ingredients. Such rising awarene …
- 自動車アクスル（車軸）・プロペラシャフトの世界市場予測（～2021年）The global automotive axle and propeller market size, in terms of value, is estimated to be USD 39.11 Billion in 2016, and is projected to grow to USD 58.07 Billion by 2021, at a CAGR of 8.22%. Growing global vehicle production, and commercialization of new technologies towards light weighting overall vehicle are expected to drive the axle and propeller shaft market. The live axle segment is set t …
- 産業用PCの世界市場予測（～2022年）：パネルPC、ラックマウントPC、ボックスPC、エンベデッドPC、エンベデッドパネルPC、DINレールPC“Industrial PC market to exhibit significant growth between 2016 and 2022”The industrial PC was valued at USD 3.30 billion in 2016 and is expected to grow at a CAGR of 6.2% to reach USD 4.73 billion by 2022. The growth in this market can be attributed to the increasing penetration of IoT across manufacturing industries, high R&D investments by the manufacturing companies to promote the adoption of …
- 世界の大型トラック市場This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
- デジタルPCR（dPCR）及び定量PCR（qPCR）の世界市場：装置、試薬、ソフトウェアThe global qPCR and dPCR market is expected to reach USD 4.94 Billion by 2021 from USD 3.28 Billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021. Digital PCR Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancem …
- ロードバランサーの世界市場予測（～2023年）Increasing awareness among enterprises about the benefits of cloud and networking technologies to fuel the demand for load balancing solution and services across the globeMarketsandMarkets expects the global load balancer market size to grow from USD 2.6 billion in 2018 to USD 5.0 billion by 2023, at a CAGR of 13.7% during the forecast period. Load balancers facilitate the distribution of network …
